Bedel Financial Consulting’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Hold |
7,562
| – | – | 0.04% | 216 |
|
|
2025
Q1 | $284K | Hold |
7,562
| – | – | 0.04% | 214 |
|
|
2024
Q4 | $285K | Sell |
7,562
-11
| -0.1% | -$415 | 0.04% | 214 |
|
|
2024
Q3 | $310K | Buy |
7,573
+11
| +0.1% | +$450 | 0.04% | 205 |
|
|
2024
Q2 | $291K | Hold |
7,562
| – | – | 0.04% | 200 |
|
|
2024
Q1 | $324K | Hold |
7,562
| – | – | 0.05% | 185 |
|
|
2023
Q4 | $280K | Buy |
7,562
+676
| +10% | +$25.1K | 0.05% | 193 |
|
|
2023
Q3 | $250K | Hold |
6,886
| – | – | 0.05% | 196 |
|
|
2023
Q2 | $245K | Buy |
6,886
+396
| +6% | +$14.1K | 0.05% | 203 |
|
|
2023
Q1 | $231K | Buy |
+6,490
| New | +$231K | 0.06% | 200 |
|
|
2022
Q2 | – | Sell |
-166
| Closed | -$9K | – | 464 |
|
|
2022
Q1 | $9K | Buy |
166
+123
| +286% | +$6.67K | ﹤0.01% | 688 |
|
|
2021
Q4 | $2K | Buy |
+43
| New | +$2K | ﹤0.01% | 884 |
|
|
2019
Q2 | – | Sell |
-40
| Closed | -$2K | – | 732 |
|
|
2019
Q1 | $2K | Hold |
40
| – | – | ﹤0.01% | 642 |
|
|
2018
Q4 | $2K | Hold |
40
| – | – | ﹤0.01% | 607 |
|
|
2018
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 647 |
|
|
2018
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 614 |
|
|
2018
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 607 |
|